Skip to main content

Table 2 Details of recurrent VTE events

From: Efficacy and safety of rivaroxaban for the treatment of PICC-related upper extremity deep vein thrombosis in cancer patients: a retrospective study

Case

anticoagulant

Recurrence location

Occurred at days of anticoagulation

Total anticoagulation duration(days)

1

nadroparin

Distal lower limbs

34

127

2

rivaroxaban

Distal lower limbs

39

157

3

rivaroxaban

Distal lower limbs

41

137

4

nadroparin

Ipsilateral IJV

65

180

  1. IJV internal jugular vein